Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Tane

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2016
Psf3 is a prognostic biomarker in lung adenocarcinoma: a larger trial using tissue microarrays of 864 consecutive resectionsShunsuke Tauchi, Yasuhiro Sakai, Shuntaro Fujimoto, et al.
Surgery Today|April 18, 2024
Clinical outcomes of left upper segmentectomy vs. lobectomy for early non-small-cell lung cancer: a nationwide database study in JapanShinya Tane, Jiro Okami, Yoshimasa Maniwa, et al.
Translational Lung Cancer Research|November 29, 2023
Exploration of a novel prognostic model based on nomogram in non-small cell lung cancer patients with distant organ metastasis: implications for immunotherapyMin Wang, Yong Zhang, Mingchuan Liu, et al.
Annals of Surgical Oncology|February 26, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective StudyShinya Tane, Megumi Nishikubo, Takehiko Manabe, et al.
JTO Clinical and Research Reports|January 7, 2026
Preoperative Immune-Related Adverse Events in Resectable NSCLC Treated With Neoadjuvant Nivolumab Plus Chemotherapy: A Multicenter Retrospective AnalysisTakuya Watanabe, Kotaro Nomura, Shinkichi Takamori, et al.
Annals of Surgical Oncology|June 17, 2026
Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung CancerShinya Tane, Kotaro Nomura, Takuya Watanabe, et al.
Annals of Surgical Oncology|June 20, 2026
ASO Visual Abstract: Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung CancerShinya Tane, Kotaro Nomura, Takuya Watanabe, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective studyMichihito Toda, Kazuki Takada, Kotaro Nomura, et al.
The Annals of Thoracic Surgery|October 31, 2025
Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus)Kotaro Nomura, Takuya Watanabe, Shinkichi Takamori, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2016
Psf3 is a prognostic biomarker in lung adenocarcinoma: a larger trial using tissue microarrays of 864 consecutive resectionsShunsuke Tauchi, Yasuhiro Sakai, Shuntaro Fujimoto, et al.
Surgery Today|April 18, 2024
Clinical outcomes of left upper segmentectomy vs. lobectomy for early non-small-cell lung cancer: a nationwide database study in JapanShinya Tane, Jiro Okami, Yoshimasa Maniwa, et al.
Translational Lung Cancer Research|November 29, 2023
Exploration of a novel prognostic model based on nomogram in non-small cell lung cancer patients with distant organ metastasis: implications for immunotherapyMin Wang, Yong Zhang, Mingchuan Liu, et al.
Annals of Surgical Oncology|February 26, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective StudyShinya Tane, Megumi Nishikubo, Takehiko Manabe, et al.
JTO Clinical and Research Reports|January 7, 2026
Preoperative Immune-Related Adverse Events in Resectable NSCLC Treated With Neoadjuvant Nivolumab Plus Chemotherapy: A Multicenter Retrospective AnalysisTakuya Watanabe, Kotaro Nomura, Shinkichi Takamori, et al.
Annals of Surgical Oncology|June 17, 2026
Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung CancerShinya Tane, Kotaro Nomura, Takuya Watanabe, et al.
Annals of Surgical Oncology|June 20, 2026
ASO Visual Abstract: Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung CancerShinya Tane, Kotaro Nomura, Takuya Watanabe, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective studyMichihito Toda, Kazuki Takada, Kotaro Nomura, et al.
The Annals of Thoracic Surgery|October 31, 2025
Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus)Kotaro Nomura, Takuya Watanabe, Shinkichi Takamori, et al.
Pageof 7